| UBE3A and its link with autism N Vatsa, NR Jana Frontiers in molecular neuroscience 11, 448, 2018 | 63 | 2018 |
| Azadiradione restores protein quality control and ameliorates the disease pathogenesis in a mouse model of Huntington’s disease BK Singh, N Vatsa, VK Nelson, V Kumar, SS Kumar, SC Mandal, M Pal, ... Molecular neurobiology 55, 6337-6346, 2018 | 36 | 2018 |
| Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer’s disease BK Singh, N Vatsa, V Kumar, S Shekhar, A Sharma, NR Jana Human Molecular Genetics 26 (20), 4042-4054, 2017 | 28 | 2017 |
| Rescue of altered HDAC activity recovers behavioural abnormalities in a mouse model of Angelman syndrome I Jamal, V Kumar, N Vatsa, S Shekhar, BK Singh, A Sharma, NR Jana Neurobiology of Disease 105, 99-108, 2017 | 28 | 2017 |
| Deficiency of Ube3a in Huntington's disease mice brain increases aggregate load and accelerates disease pathology M Maheshwari, S Shekhar, BK Singh, I Jamal, N Vatsa, V Kumar, ... Human molecular genetics 23 (23), 6235-6245, 2014 | 27 | 2014 |
| Down-regulation of miRNA-708 promotes aberrant calcium signaling by targeting neuronatin in a mouse model of angelman syndrome N Vatsa, V Kumar, BK Singh, SS Kumar, A Sharma, NR Jana Frontiers in Molecular Neuroscience 12, 35, 2019 | 26 | 2019 |
| Environmental enrichment improves behavioral abnormalities in a mouse model of Angelman syndrome I Jamal, V Kumar, N Vatsa, BK Singh, S Shekhar, A Sharma, NR Jana Molecular neurobiology 54, 5319-5326, 2017 | 15 | 2017 |
| Simvastatin restores HDAC1/2 activity and improves behavioral deficits in Angelman syndrome model mouse V Kumar, T Joshi, N Vatsa, BK Singh, NR Jana Frontiers in Molecular Neuroscience 12, 289, 2019 | 14 | 2019 |
| Topoisomerase 1 inhibitor topotecan delays the disease progression in a mouse model of Huntington’s disease S Shekhar, N Vatsa, V Kumar, BK Singh, I Jamal, A Sharma, NR Jana Human molecular genetics 26 (2), 420-429, 2017 | 12 | 2017 |
| An acute microglial metabolic response controls metabolism and improves memory A Drougard, EH Ma, V Wegert, R Sheldon, I Panzeri, N Vatsa, S Apostle, ... Elife 12, RP87120, 2024 | 8 | 2024 |
| Pathological α-synuclein elicits granulovacuolar degeneration independent of tau DJ Dues, ML Erb, A Kasen, N Vatsa, ET Williams, APT Nguyen, ... bioRxiv, 2024.12. 27.630547, 2024 | | 2024 |
| Network analysis of α-synuclein pathology progression reveals p21-activated kinases as regulators of vulnerability N Vatsa, JK Brynildsen, TM Goralski, K Kurgat, L Meyerdirk, L Breton, ... bioRxiv, 2024 | | 2024 |
| Immunocytochemistry M Henderson, N Vatsa | | 2024 |
| Tet2 loss suppress α-synuclein pathology by stimulating ciliogenesis Q Emmanuel, V Naman, E Elizabeth, B Jaycie, C Tyce, A Miguel, K Emily, ... bioRxiv, 2024 | | 2024 |
| A rapid microglial metabolic response controls metabolism and improves memory A Drougard, EH Ma, V Wegert, R Sheldon, I Panzeri, N Vatsa, S Apostle, ... bioRxiv, 2023.04. 03.535373, 2023 | | 2023 |
| Acknowledgment to the Reviewers of Brain Sciences in 2022 Brain Sciences Editorial Office Brain Sciences 13 (2), 169, 2023 | | 2023 |
| Acknowledgment to the Reviewers of Biology in 2022 Biology Editorial Office Biology 12 (1), 137, 2023 | | 2023 |
| Topotecan, a Topoisomerase-1 Inhibitor, Retards the Disease Pathogenesis in a Mouse Model of Huntington's Disease SS Kumar, N Vatsa, V Kumar, BK Singh, I Jamal, A Sharma, NR Jana NEUROTHERAPEUTICS 15 (1), 252-252, 2018 | | 2018 |
Nihar JanaDepartment of Bioscience and Biotechnology, Indian Institute of Technology, KharagpurVerified email at iitkgp.ac.in
